0001225208-13-013426.txt : 20130529
0001225208-13-013426.hdr.sgml : 20130529
20130529153448
ACCESSION NUMBER: 0001225208-13-013426
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130523
FILED AS OF DATE: 20130529
DATE AS OF CHANGE: 20130529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MOREL DONALD E JR
CENTRAL INDEX KEY: 0001213306
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08036
FILM NUMBER: 13878241
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC
CENTRAL INDEX KEY: 0000105770
STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060]
IRS NUMBER: 231210010
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 GORDON DR
STREET 2: P O BOX 645
CITY: LIONVILLE
STATE: PA
ZIP: 19341-0645
BUSINESS PHONE: 6105942900
MAIL ADDRESS:
STREET 1: 101 GORDON DRIVE
STREET 2: PO BOX 645
CITY: LIONVILLE
STATE: PA
ZIP: 19341-0645
FORMER COMPANY:
FORMER CONFORMED NAME: WEST CO INC
DATE OF NAME CHANGE: 19990405
4
1
doc4.xml
X0306
4
2013-05-23
0000105770
WEST PHARMACEUTICAL SERVICES INC
WST
0001213306
MOREL DONALD E JR
530 HERMAN O. WEST DRIVE
EXTON
PA
19341
1
Chair of the Board & CEO
Common Stock
2013-05-23
4
M
0
100825.0000
41.7000
A
603993.4076
D
Common Stock
2013-05-23
4
M
0
96576.0000
44.9700
A
700569.4076
D
Common Stock
2013-05-23
4
F
0
79142.0000
67.6100
D
621427.4076
D
Common Stock
2013-05-23
4
F
0
79995.0000
67.6100
D
541432.4076
D
Common Stock
2013-05-28
4
S
0
5000.0000
68.0390
D
536432.4076
D
Common Stock
2013-05-28
4
S
0
5000.0000
67.7030
D
531432.4076
D
Common Stock
2013-05-24
4
A
0
18.8400
67.3800
A
20527.2048
I
Non-Qualified Deferred Compensation Plan
Common Stock
1335.6398
I
By Savings Plan
Stock Option (Right to Buy)
41.7000
2013-05-23
4
M
0
100825.0000
41.7000
D
2009-02-26
2018-02-26
Common Stock
100825.0000
0.0000
D
Stock Option (Right to Buy)
44.9700
2013-05-23
4
M
0
96576.0000
44.9700
D
2008-02-27
2018-02-27
Common Stock
96576.0000
0.0000
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.48 to $68.30, inclusive. The reporting person undertakes to provide to any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in foonotes (1) and (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.45 to $67.98, inclusive.
Joanne K. Boyle as Agent for Donald E. Morel, Jr.
2013-05-29